PROSTATE_CANCER

作品数：1256被引量：2510H指数：19
导出分析报告
相关作者：王增军邱实黄鹰段秀枝魏强更多>>
相关机构：浙江大学医学院附属第二医院江苏省人民医院复旦大学上海交通大学医学院附属第九人民医院更多>>
相关期刊：更多>>
相关基金：国家自然科学基金国家重点基础研究发展计划广东省自然科学基金北京市自然科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 基金=World Health Organizationx
共 条 记 录，以下是1-4
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots被引量：1
《Asian Journal of Urology》2017年第4期208-222,共15页Per-Anders Abrahamsson 
Ferring Pharmaceuticals provided funding for editorial assistance.The author acknowledges Dr.Payal Bhardwaj of Tata Consultancy Services,who provided editorial assistance.
Intermittent androgen deprivation therapy(IADT)is now being increasingly opted by the treating physicians and patients with prostate cancer.The most common reason driving this is the availability of an off-treatment p...
关键词：Continuous androgen deprivation therapy Intermittent androgen deprivation therapy Prostate cancer Study designs and outcomes Tumor burden 
Non-invasive actionable biomarkers for metastatic prostate cancer被引量：1
《Asian Journal of Urology》2016年第4期170-176,共7页Jun Luo 
Due to limited scope of the review,many published studies that formed the basis for viewpoints expressed in this review were not cited;The author wishes to thank all investigators who contributed to the knowledge and insight in the topic covered in this review.The author’s laboratory is currently funded by a Prostate Cancer Foundation grant,an NIH grant R01 CA185297;US Department of Defense Prostate Cancer Research Program grants W81XWH-13-2-0093 and W81XWH-15-2-0050.
In the current clinical setting,many disease management options are available for men diagnosed with prostate cancer.For metastatic prostate cancer,first-line therapies almost always involve agents designed to inhibit...
关键词：Prostate cancer Androgen receptor AR-V7 BIOMARKER CRPC 
Mismatch repair enzyme expression in primary and castrate resistant prostate cancer被引量：2
《Asian Journal of Urology》2016年第4期223-228,共6页Belinda Nghiem Xiaotun Zhang Hung-Ming Lam Lawrence DTrue Ilsa Coleman Celestia SHigano Peter SNelson Colin CPritchard Colm Morrissey 
We thank the patients and their families who were willing to participate in the Prostate Cancer Donor Program.The investigators Drs.Robert Vessella,Bruce Montgomery,Evan Yu,Heather Cheng,Elahe Mostaghel,Paul Lange,and Martine Roudier for their contributions to the University of Washington Medical Center Prostate Cancer Donor Rapid Autopsy Program;his research was supported by funding by the Pacific Northwest Prostate Cancer SPORE(P50CA97186),R01CA165573;the Richard M.LUCAS Foundation.Colm Morrissey is a recipient of a Career Development Award from Jim and Catherine Allchin.
Objective:Although the utility of immunohistochemistry(IHC)for assessing mismatch repair(MMR)protein expression has been demonstrated in solid tumors including primary prostate cancer(PCa),its utility has not been ass...
关键词：Mismatch repair Castration resistant prostate cancer MLH1 MSH2 MSH6 PMS2 
Ability of community-based prostate cancer screening to target an appropriate and underserved population
《World Journal of Methodology》2015年第2期10-12,共3页Jared Moss Eric Heidel Jason Johnson Chase Powell Erin Dittrich Susan Rawn Paul D Terry Mitchell Goldman W Bedford Waters Wesley M White 
the men who participated in prostate cancer screening at the University of Tennessee Medical Center.No external financial support
Screening is not universally beneficial due to over-and under-diagnosis,and false positives that beget additionaltesting and associated adverse events and expense.We examined data from all men who participated in a ma...
关键词：Prostate cancer Screening OUTCOMES Prostate specifc antigen Community health 
全选清除导出
共1页<1>
检索报告 对象比较 聚类工具 使用帮助 返回顶部